Table 3.

Distribution of TCIM users in relation to diagnosis.

TCIM intake period	BP (n=228)				MBP (n=191)
	n		%	%	n	%	n	%
Before diagnosis	15	6.6%			10
After diagnosis	162	71.1%				151	5.2%
After diagnosis, before therapy or surgery During therapy After therapy			36 101 63	15.8 44.3 27.6			22 60 86	11.5% 31.4% 45.0%
Regardless of the disease, others, or no answer	47	20.6%			71	37.2%
	18	7.9%			14	7.3%